Research and Markets: Psoriasis Partnering 2007-2013 Report is Essential Reading for those inside the Dermatology Field

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/zf25lt/psoriasis) has announced the addition of the "Psoriasis Partnering 2007-2013" report to their offering.

Psoriasis Partnering 2007-2013 report provides understanding and access to the psoriasis partnering deals and agreements entered into by the world's leading healthcare companies.

- Trends in psoriasis partnering deals

- Top psoriasis deals by value

- Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides an analysis of psoriasis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors psoriasis technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains over 50 links to online copies of actual liver disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

More:
Research and Markets: Psoriasis Partnering 2007-2013 Report is Essential Reading for those inside the Dermatology Field